Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis.
Mattos WLLD, Khalil N, Spencer LG, Bonella F, Folz RJ, Rolf JD, Mogulkoc N, Lancaster LH, Jenkins RG, Lynch DA, Noble PW, Maher TM, Cottin V, Senger S, Horan GS, Greenberg S, Popmihajlov Z.
Mattos WLLD, et al. Among authors: rolf jd.
Am J Respir Crit Care Med. 2024 Mar 14. doi: 10.1164/rccm.202310-1907OC. Online ahead of print.
Am J Respir Crit Care Med. 2024.
PMID: 38484130